tiprankstipranks
Trending News
More News >

PacBio price target lowered to $1.25 from $2 at Piper Sandler

Piper Sandler lowered the firm’s price target on PacBio (PACB) to $1.25 from $2 following quarterly results. The firm keeps a Neutral rating on the shares.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1